HomeINDP • NASDAQ
add
Indaptus Therapeutics Inc
Previous close
$2.65
Day range
$2.45 - $2.57
Year range
$1.66 - $47.60
Market cap
4.50M USD
Avg Volume
44.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.65M | -15.71% |
Net income | -2.98M | 3.06% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.65M | 15.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.83M | -21.07% |
Total assets | 6.84M | -16.99% |
Total liabilities | 2.23M | -0.10% |
Total equity | 4.61M | — |
Shares outstanding | 1.75M | — |
Price to book | 0.94 | — |
Return on assets | -96.81% | — |
Return on capital | -139.72% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.98M | 3.06% |
Cash from operations | -2.57M | -2.16% |
Cash from investing | — | — |
Cash from financing | 2.24M | -13.76% |
Net change in cash | -332.06K | -520.68% |
Free cash flow | -1.61M | -26.20% |
About
Founded
2021
Website
Employees
7
